{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T07:48:03Z","timestamp":1782114483910,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00241664"],"award-info":[{"award-number":["RS-2023-00241664"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research Foundation of Korea, South Korea","award":["RS-2024-00354246"],"award-info":[{"award-number":["RS-2024-00354246"]}]},{"name":"National Research Foundation of Korea, South Korea","award":["RS-2024-00336383"],"award-info":[{"award-number":["RS-2024-00336383"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Part Fibre Toxicol"],"DOI":"10.1186\/s12989-026-00687-4","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T03:55:18Z","timestamp":1780804518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the PPAR-\u03b3-ABC transporter axis ameliorates secondary pulmonary alveolar proteinosis induced by indium oxide nanoparticles"],"prefix":"10.1186","volume":"23","author":[{"given":"Soyeon","family":"Jeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyuri","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Seob","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,7]]},"reference":[{"issue":"6","key":"687_CR1","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1084\/jem.190.6.875","volume":"190","author":"T Kitamura","year":"1999","unstructured":"Kitamura T, Tanaka N, Watanabe J, Uchida, Kanegasaki S, Yamada Y, Nakata K. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte\/macrophage colony-stimulating factor. J Exp Med. 1999;190(6):875\u201380.","journal-title":"J Exp Med"},{"issue":"1","key":"687_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-019-0066-3","volume":"5","author":"BC Trapnell","year":"2019","unstructured":"Trapnell BC, Nakata K, Bonella F, Campo I, Griese M, Hamilton J, Wang T, Morgan C, Cottin V, McCarthy C. Pulmonary alveolar proteinosis. Nat Rev Dis Primers. 2019;5(1):16.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"687_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/thorax.55.1.67","volume":"55","author":"PL Shah","year":"2000","unstructured":"Shah PL, Hansell D, Lawson PR, Reid KB, Morgan C. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax. 2000;55(1):67\u201377.","journal-title":"Thorax"},{"issue":"2","key":"687_CR4","doi-asserted-by":"publisher","first-page":"200018","DOI":"10.1183\/20734735.0018-2020","volume":"16","author":"E Salvaterra","year":"2020","unstructured":"Salvaterra E, Campo I. Pulmonary alveolar proteinosis: from classification to therapy. Breathe (Sheff). 2020;16(2):200018.","journal-title":"Breathe (Sheff)"},{"issue":"2","key":"687_CR5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1164\/arrd.1984.130.2.312","volume":"130","author":"RR Miller","year":"1984","unstructured":"Miller RR, Churg AM, Hutcheon M, Lom S. Pulmonary alveolar proteinosis and aluminum dust exposure. Am Rev Respir Dis. 1984;130(2):312\u20135.","journal-title":"Am Rev Respir Dis"},{"issue":"13","key":"687_CR6","doi-asserted-by":"publisher","first-page":"7092","DOI":"10.3390\/ijms25137092","volume":"25","author":"J Woloszczak","year":"2024","unstructured":"Woloszczak J, Wrzesniewska M, Hrapkowicz A, Janowska K, Szydziak J, Gomulka K. A Comprehensive Outlook on Pulmonary Alveolar Proteinosis-A Review. Int J Mol Sci. 2024;25(13):7092.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"687_CR7","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1080\/17435390.2019.1694184","volume":"14","author":"SH Kim","year":"2020","unstructured":"Kim SH, Jeon S, Lee DK, Lee S, Jeong J, Kim JS, Cho WS. The early onset and persistent worsening pulmonary alveolar proteinosis in rats by indium oxide nanoparticles. Nanotoxicology. 2020;14(4):468\u201378.","journal-title":"Nanotoxicology"},{"issue":"4","key":"687_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00204-015-1493-x","volume":"90","author":"J Jeong","year":"2016","unstructured":"Jeong J, Kim J, Seok SH, Cho WS. Indium oxide (In2O3) nanoparticles induce progressive lung injury distinct from lung injuries by copper oxide (CuO) and nickel oxide (NiO) nanoparticles. Arch Toxicol. 2016;90(4):817\u201328.","journal-title":"Arch Toxicol"},{"key":"687_CR9","doi-asserted-by":"publisher","first-page":"126595","DOI":"10.1016\/j.jhazmat.2021.126595","volume":"420","author":"S Jeon","year":"2021","unstructured":"Jeon S, Kim SH, Jeong J, Lee DK, Lee S, Kim S, Kim G, Maruthupandy M, Cho WS. ABCG1 and ABCG4 as key transporters in the development of pulmonary alveolar proteinosis by nanoparticles. J Hazard Mater. 2021;420:126595.","journal-title":"J Hazard Mater"},{"key":"687_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1743-8977-11-18","volume":"11","author":"HM Braakhuis","year":"2014","unstructured":"Braakhuis HM, Park MV, Gosens I, De Jong WH, Cassee FR. Physicochemical characteristics of nanomaterials that affect pulmonary inflammation. Part Fibre Toxicol. 2014;11:18.","journal-title":"Part Fibre Toxicol"},{"issue":"6","key":"687_CR11","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1194\/jlr.M001651","volume":"51","author":"AD Baker","year":"2010","unstructured":"Baker AD, Malur A, Barna BP, Ghosh S, Kavuru MS, Malur AG, Thomassen MJ. Targeted PPARgamma deficiency in alveolar macrophages disrupts surfactant catabolism. J Lipid Res. 2010;51(6):1325\u201331.","journal-title":"J Lipid Res"},{"issue":"1","key":"687_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12989-025-00624-x","volume":"22","author":"L Perez","year":"2025","unstructured":"Perez L, Ambroise J, Bearzatto B, Froidure A, Pilette C, Yakoub Y, Palmai-Pallag M, Bouzin C, Ryelandt L, Pavan C, et al. Unique transcriptomic responses of rat and human alveolar macrophages in an in vitro model of overload with TiO(2) and carbon black. Part Fibre Toxicol. 2025;22(1):8.","journal-title":"Part Fibre Toxicol"},{"key":"687_CR13","doi-asserted-by":"crossref","unstructured":"Lettieri S, Bonella F, Marando VA, Franciosi AN, Corsico AG, Campo I. Pathogenesis-driven treatment of primary pulmonary alveolar proteinosis. Eur Respir Rev 2024, 33(173).","DOI":"10.1183\/16000617.0064-2024"},{"issue":"1","key":"687_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12944-020-01278-8","volume":"19","author":"CW Agudelo","year":"2020","unstructured":"Agudelo CW, Samaha G, Garcia-Arcos I. Alveolar lipids in pulmonary disease. A review. Lipids Health Dis. 2020;19(1):122.","journal-title":"Lipids Health Dis"},{"key":"687_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1743-8977-10-19","volume":"10","author":"M Geiser","year":"2013","unstructured":"Geiser M, Quaile O, Wenk A, Wigge C, Eigeldinger-Berthou S, Hirn S, Schaffler M, Schleh C, Moller W, Mall MA, et al. Cellular uptake and localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive pulmonary disease. Part Fibre Toxicol. 2013;10:19.","journal-title":"Part Fibre Toxicol"},{"issue":"6","key":"687_CR16","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1517\/17425247.2015.1039509","volume":"12","author":"WH Lee","year":"2015","unstructured":"Lee WH, Loo CY, Traini D, Young PM. Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages. Expert Opin Drug Deliv. 2015;12(6):1009\u201326.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"687_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13023-016-0497-9","volume":"11","author":"I Campo","year":"2016","unstructured":"Campo I, Luisetti M, Griese M, Trapnell BC, Bonella F, Grutters J, Nakata K, Van Moorsel CH, Costabel U, Cottin V, et al. Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures. Orphanet J Rare Dis. 2016;11(1):115.","journal-title":"Orphanet J Rare Dis"},{"key":"687_CR18","first-page":"100756","volume":"78","author":"C Dupin","year":"2020","unstructured":"Dupin C, Hurtado M, Cazes A, Taille C, Debray MP, Guenee C, Tabeze L, Crestani B, Borie R. Pioglitazone in pulmonary alveolar proteinosis: promising first clinical experience. Respir Med Res. 2020;78:100756.","journal-title":"Respir Med Res"},{"issue":"7","key":"687_CR19","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.3390\/ijms22073308","volume":"22","author":"M Hetzel","year":"2021","unstructured":"Hetzel M, Ackermann M, Lachmann N. Beyond Big Eaters: The Versatile Role of Alveolar Macrophages in Health and Disease. Int J Mol Sci. 2021;22(7):3308.","journal-title":"Int J Mol Sci"},{"key":"687_CR20","doi-asserted-by":"publisher","first-page":"138518","DOI":"10.1016\/j.jhazmat.2025.138518","volume":"494","author":"J Jeong","year":"2025","unstructured":"Jeong J, Kim S, Rethinasabapathy M, Yang YJ, Huh YS, Cho WS. Biotransformation of iron oxide nanoparticles and their impact on biokinetics in rats following intratracheal instillation. J Hazard Mater. 2025;494:138518.","journal-title":"J Hazard Mater"},{"issue":"12","key":"687_CR21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/15459624.2013.836279","volume":"10","author":"CJ Hines","year":"2013","unstructured":"Hines CJ, Roberts JL, Andrews RN, Jackson MV, Deddens JA. Use of and occupational exposure to indium in the United States. J Occup Environ Hyg. 2013;10(12):723\u201333.","journal-title":"J Occup Environ Hyg"},{"issue":"6","key":"687_CR22","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1074\/jbc.272.6.3406","volume":"272","author":"JM Lehmann","year":"1997","unstructured":"Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem. 1997;272(6):3406\u201310.","journal-title":"J Biol Chem"},{"issue":"13\u201314","key":"687_CR23","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.intimp.2006.07.024","volume":"6","author":"MG Pereira","year":"2006","unstructured":"Pereira MG, Camara NO, Campaholle G, Cenedeze MA, de Paula Antunes Teixeira V, dos Reis MA, Pacheco-Silva A. Pioglitazone limits cyclosporine nephrotoxicity in rats. Int Immunopharmacol. 2006;6(13\u201314):1943\u201351.","journal-title":"Int Immunopharmacol"},{"issue":"Pt 1","key":"687_CR24","doi-asserted-by":"publisher","first-page":"132822","DOI":"10.1016\/j.chemosphere.2021.132822","volume":"291","author":"AL Moreno Rios","year":"2022","unstructured":"Moreno Rios AL, Gutierrez-Suarez K, Carmona Z, Ramos CG, Silva Oliveira LF. Pharmaceuticals as emerging pollutants: Case naproxen an overview. Chemosphere. 2022;291(Pt 1):132822.","journal-title":"Chemosphere"},{"issue":"1","key":"687_CR25","doi-asserted-by":"publisher","first-page":"e013470","DOI":"10.1161\/JAHA.119.013470","volume":"9","author":"X Jiang","year":"2020","unstructured":"Jiang X, Liu X, Liu X, Wu X, Jose PA, Liu M, Yang Z. Low-Dose Aspirin Treatment Attenuates Male Rat Salt-Sensitive Hypertension via Platelet Cyclooxygenase 1 and Complement Cascade Pathway. J Am Heart Assoc. 2020;9(1):e013470.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"687_CR26","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1164\/rccm.200907-1022CR","volume":"181","author":"KJ Cummings","year":"2010","unstructured":"Cummings KJ, Donat WE, Ettensohn DB, Roggli VL, Ingram P, Kreiss K. Pulmonary alveolar proteinosis in workers at an indium processing facility. Am J Respir Crit Care Med. 2010;181(5):458\u201364.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"687_CR27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1183\/09031936.00047111","volume":"39","author":"WS Cho","year":"2012","unstructured":"Cho WS, Duffin R, Bradley M, Megson IL, Macnee W, Howie SE, Donaldson K. NiO and Co3O4 nanoparticles induce lung DTH-like responses and alveolar lipoproteinosis. Eur Respir J. 2012;39(3):546\u201357.","journal-title":"Eur Respir J"},{"issue":"3","key":"687_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","volume":"145","author":"KJ Moore","year":"2011","unstructured":"Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341\u201355.","journal-title":"Cell"},{"issue":"2","key":"687_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nri3793","volume":"15","author":"AR Tall","year":"2015","unstructured":"Tall AR, Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat Rev Immunol. 2015;15(2):104\u201316.","journal-title":"Nat Rev Immunol"},{"key":"687_CR30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.scitotenv.2018.02.312","volume":"631\u2013632","author":"C Guo","year":"2018","unstructured":"Guo C, Ma R, Liu X, Chen T, Li Y, Yu Y, Duan J, Zhou X, Li Y, Sun Z. Silica nanoparticles promote oxLDL-induced macrophage lipid accumulation and apoptosis via endoplasmic reticulum stress signaling. Sci Total Environ. 2018;631\u2013632:570\u20139.","journal-title":"Sci Total Environ"},{"issue":"4","key":"687_CR31","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1111\/jcmm.14203","volume":"23","author":"H Tian","year":"2019","unstructured":"Tian H, Li Y, Kang P, Wang Z, Yue F, Jiao P, Yang N, Qin S, Yao S. Endoplasmic reticulum stress-dependent autophagy inhibits glycated high-density lipoprotein-induced macrophage apoptosis by inhibiting CHOP pathway. J Cell Mol Med. 2019;23(4):2954\u201369.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"687_CR32","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3390\/cells13110889","volume":"13","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Choi D, Somanath PR, Zhang D. Lipid-Laden Macrophages in Pulmonary Diseases. Cells. 2024;13(11):889.","journal-title":"Cells"},{"key":"687_CR33","doi-asserted-by":"publisher","first-page":"26162","DOI":"10.1038\/srep26162","volume":"6","author":"A Naji","year":"2016","unstructured":"Naji A, Muzembo BA, Yagyu K, Baba N, Deschaseaux F, Sensebe L, Suganuma N. Endocytosis of indium-tin-oxide nanoparticles by macrophages provokes pyroptosis requiring NLRP3-ASC-Caspase1 axis that can be prevented by mesenchymal stem cells. Sci Rep. 2016;6:26162.","journal-title":"Sci Rep"},{"issue":"1","key":"687_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1097-2765(01)00164-2","volume":"7","author":"A Chawla","year":"2001","unstructured":"Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, et al. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell. 2001;7(1):161\u201371.","journal-title":"Mol Cell"},{"issue":"11\u201312","key":"687_CR35","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s10495-023-01888-4","volume":"28","author":"G Yang","year":"2023","unstructured":"Yang G, Yang Y, Liu Y, Liu X. Regulation of alveolar macrophage death in pulmonary fibrosis: a review. Apoptosis. 2023;28(11\u201312):1505\u201319.","journal-title":"Apoptosis"},{"issue":"23","key":"687_CR36","doi-asserted-by":"publisher","first-page":"6008","DOI":"10.3390\/ijms20236008","volume":"20","author":"S Kany","year":"2019","unstructured":"Kany S, Vollrath JT, Relja B. Cytokines in Inflammatory Disease. Int J Mol Sci. 2019;20(23):6008.","journal-title":"Int J Mol Sci"},{"key":"687_CR37","doi-asserted-by":"publisher","first-page":"752856","DOI":"10.3389\/fimmu.2021.752856","volume":"12","author":"A Ataya","year":"2021","unstructured":"Ataya A, Knight V, Carey BC, Lee E, Tarling EJ, Wang T. The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review. Front Immunol. 2021;12:752856.","journal-title":"Front Immunol"},{"issue":"6","key":"687_CR38","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/jir.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29(6):313\u201326.","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"687_CR39","doi-asserted-by":"publisher","first-page":"17284","DOI":"10.1038\/s41598-017-17645-y","volume":"7","author":"M Shoeb","year":"2017","unstructured":"Shoeb M, Joseph P, Kodali V, Mustafa G, Farris BY, Umbright C, Roberts JR, Erdely A, Antonini JM. Silica inhalation altered telomere length and gene expression of telomere regulatory proteins in lung tissue of rats. Sci Rep. 2017;7(1):17284.","journal-title":"Sci Rep"},{"issue":"10","key":"687_CR40","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3858\/emm.2009.41.10.082","volume":"41","author":"JH Lim","year":"2009","unstructured":"Lim JH, Um HJ, Park JW, Lee IK, Kwon TK. Interleukin-1beta promotes the expression of monocyte chemoattractant protein-1 in human aorta smooth muscle cells via multiple signaling pathways. Exp Mol Med. 2009;41(10):757\u201364.","journal-title":"Exp Mol Med"},{"issue":"6","key":"687_CR41","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/01.ATV.0000019009.73586.7F","volume":"22","author":"C Viedt","year":"2002","unstructured":"Viedt C, Vogel J, Athanasiou T, Shen W, Orth SR, Kubler W, Kreuzer J. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1. Arterioscler Thromb Vasc Biol. 2002;22(6):914\u201320.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"687_CR42","unstructured":"Ghlichloo I, Gerriets V. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). In: StatPearls. Treasure Island (FL); 2025."},{"key":"687_CR43","doi-asserted-by":"crossref","unstructured":"Lands LC, Stanojevic S. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis. Cochrane Database Syst Rev 2013(6):CD001505.","DOI":"10.1002\/14651858.CD001505.pub3"},{"issue":"6","key":"687_CR44","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.bcp.2008.12.012","volume":"77","author":"P Castro","year":"2009","unstructured":"Castro P, Nasser H, Abrahao A, Dos Reis LC, Rica I, Valenca SS, Rezende DC, Quintas LE, Cavalcante MC, Porto LC, et al. Aspirin and indomethacin reduce lung inflammation of mice exposed to cigarette smoke. Biochem Pharmacol. 2009;77(6):1029\u201339.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"687_CR45","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1080\/21655979.2021.1955560","volume":"12","author":"Y Wu","year":"2021","unstructured":"Wu Y, Hao R, Lan B, Mu Y, Dang F, Wang R. The protective effects of naproxen against interleukin-1beta (IL-1beta)- induced damage in human umbilical vein endothelial cells (HUVECs). Bioengineered. 2021;12(1):5361\u201372.","journal-title":"Bioengineered"},{"issue":"4","key":"687_CR46","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/imm.13200","volume":"160","author":"DP Dyer","year":"2020","unstructured":"Dyer DP. Understanding the mechanisms that facilitate specificity, not redundancy, of chemokine-mediated leukocyte recruitment. Immunology. 2020;160(4):336\u201344.","journal-title":"Immunology"},{"key":"687_CR47","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3389\/fimmu.2020.01259","volume":"11","author":"A Capucetti","year":"2020","unstructured":"Capucetti A, Albano F, Bonecchi R. Multiple Roles for Chemokines in Neutrophil Biology. Front Immunol. 2020;11:1259.","journal-title":"Front Immunol"},{"issue":"8","key":"687_CR48","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41419-019-1806-8","volume":"10","author":"S Keshavan","year":"2019","unstructured":"Keshavan S, Calligari P, Stella L, Fusco L, Delogu LG, Fadeel B. Nano-bio interactions: a neutrophil-centric view. Cell Death Dis. 2019;10(8):569.","journal-title":"Cell Death Dis"},{"issue":"10\u201311","key":"687_CR49","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/S1567-5769(03)00179-6","volume":"3","author":"T Kimura","year":"2003","unstructured":"Kimura T, Iwase M, Kondo G, Watanabe H, Ohashi M, Ito D, Nagumo M. Suppressive effect of selective cyclooxygenase-2 inhibitor on cytokine release in human neutrophils. Int Immunopharmacol. 2003;3(10\u201311):1519\u201328.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"687_CR50","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2337\/diacare.25.3.517","volume":"25","author":"Y Miyazaki","year":"2002","unstructured":"Miyazaki Y, Matsuda M, DeFronzo RA. Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes. Diabetes Care. 2002;25(3):517\u201323.","journal-title":"Diabetes Care"},{"key":"687_CR51","unstructured":"Munjal A, Allam AE. Indomethacin. In: StatPearls. Treasure Island (FL); 2025."},{"issue":"10","key":"687_CR52","doi-asserted-by":"publisher","first-page":"e109886","DOI":"10.1371\/journal.pone.0109886","volume":"9","author":"O Sano","year":"2014","unstructured":"Sano O, Ito S, Kato R, Shimizu Y, Kobayashi A, Kimura Y, Kioka N, Hanada K, Ueda K, Matsuo M. ABCA1, ABCG1, and ABCG4 are distributed to distinct membrane meso-domains and disturb detergent-resistant domains on the plasma membrane. PLoS ONE. 2014;9(10):e109886.","journal-title":"PLoS ONE"},{"issue":"2","key":"687_CR53","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/ATVBAHA.108.179283","volume":"30","author":"L Yvan-Charvet","year":"2010","unstructured":"Yvan-Charvet L, Wang N, Tall AR. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol. 2010;30(2):139\u201343.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"687_CR54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/CIRCRESAHA.114.300738","volume":"114","author":"M Westerterp","year":"2014","unstructured":"Westerterp M, Bochem AE, Yvan-Charvet L, Murphy AJ, Wang N, Tall AR. ATP-binding cassette transporters, atherosclerosis, and inflammation. Circ Res. 2014;114(1):157\u201370.","journal-title":"Circ Res"}],"container-title":["Particle and Fibre Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12989-026-00687-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12989-026-00687-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12989-026-00687-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T07:04:46Z","timestamp":1782111886000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12989-026-00687-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,7]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1186\/s12989-026-00687-4","relation":{},"ISSN":["1743-8977"],"issn-type":[{"value":"1743-8977","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,7]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee at Dong-A University (IACUC-DAU23-09).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}